First Horizon Advisors Inc. Sells 225 Shares of HealthEquity, Inc. (NASDAQ:HQY)

First Horizon Advisors Inc. lowered its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 20.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 852 shares of the company’s stock after selling 225 shares during the quarter. First Horizon Advisors Inc.’s holdings in HealthEquity were worth $56,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HQY. FMR LLC raised its position in shares of HealthEquity by 19.1% in the 3rd quarter. FMR LLC now owns 5,648,992 shares of the company’s stock valued at $412,659,000 after purchasing an additional 907,743 shares during the last quarter. Mackenzie Financial Corp raised its holdings in shares of HealthEquity by 58.2% in the fourth quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock worth $119,831,000 after buying an additional 664,979 shares during the last quarter. Invesco Ltd. grew its holdings in shares of HealthEquity by 164.6% during the third quarter. Invesco Ltd. now owns 484,043 shares of the company’s stock valued at $35,359,000 after buying an additional 301,078 shares during the last quarter. Clearbridge Investments LLC boosted its holdings in shares of HealthEquity by 12.1% in the 3rd quarter. Clearbridge Investments LLC now owns 2,204,675 shares of the company’s stock valued at $161,051,000 after acquiring an additional 238,116 shares during the last quarter. Finally, Eagle Asset Management Inc. acquired a new stake in HealthEquity during the 3rd quarter worth about $15,581,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of recent research reports. BTIG Research upped their target price on HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, March 20th. Bank of America boosted their target price on shares of HealthEquity from $93.00 to $97.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of HealthEquity in a report on Friday, March 22nd. Barclays increased their target price on shares of HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a research note on Friday, February 23rd. Finally, Royal Bank of Canada upped their price target on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $96.17.

HealthEquity Stock Performance

NASDAQ HQY opened at $80.38 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. HealthEquity, Inc. has a 1-year low of $53.15 and a 1-year high of $84.49. The company has a market cap of $6.90 billion, a PE ratio of 125.59, a price-to-earnings-growth ratio of 1.28 and a beta of 0.55. The stock’s 50 day simple moving average is $80.66 and its 200-day simple moving average is $74.72.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.08. The company had revenue of $262.39 million for the quarter, compared to analysts’ expectations of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. As a group, equities research analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 2,499 shares of HealthEquity stock in a transaction that occurred on Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares in the company, valued at $3,999,680. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, CEO Jon Kessler sold 33,765 shares of the company’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the transaction, the chief executive officer now directly owns 126,635 shares in the company, valued at $10,106,739.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Delano Ladd sold 2,499 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $80.00, for a total value of $199,920.00. Following the sale, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at approximately $3,999,680. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,322 shares of company stock valued at $5,682,895. Corporate insiders own 2.70% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.